Friday, 30 August
| 17.00-18.00 | Pre-symposium, Astellas |
| 18.00-19.00 | Candle light lecture: Is the progression of DKD preventable? Prof. Dick de Zeeuw, Groningen, NL |
| 19.30- | Get-together party |
Saturday, 31 August
| 8.00-9.00 | Industry symposium 1, Nordic Medcom / Carbonex Oy |
| 9.00-10.30 | Session 1 – Transplantation (chair: Kaj Metsärinne, Turku, FIN) |
| Optimizing the living donor pool – experiences from a successful exchange program J. van de Wetering, Rotterdam, NL Risks for the living donor Geir Mjoen, Oslo, NO Current risks and benefits for the kidney transplant recipient Ilkka Helanterä, Helsinki, FIN |
|
| 10.30-11.00 | Coffee & exhibition |
| 11.00-12.30 | Session 2 – Homedialysis (chair Eero Honkanen, Helsinki, FIN) |
| Critical analysis of Quality of life in different dialysis modalities Patrik Finne, Helsinki, FIN Health economic perspectives on home dialysis Helena Rydell, Stockholm, SWE Role of home dialysis in dialysis strategy planning Marianne Rix, Copenhagen, DEN |
|
| 12.30-13.30 | Lunch and exhibition |
| 13.30-15.00 | Session 3 – Diabetes and kidney disease (chair Per-Henrik Groop, FIN) |
| New classification of diabetes – implications for DKD? Leif Groop, FIN & SWE Functional MRI – the new kidney biopsy? Aghogho Odudu, Manchester, UK Diabetic complications in individuals living with type 1 diabetes for more than 50 years D. Pongrac-Barlovic Ljubljana, SLO |
|
| 15.00-15.30 | Coffee and exhibition |
| 15.30-16.30 | Session 4 – Genetics and pathophysiology of renal diseases (chair: Hannu Jalanko, Helsinki, FIN) |
| Complement system in kidney disease Seppo Meri, Helsinki, FIN Genetics and podocyte pathology in nephrotic syndrome Jaakko Patrakka, Stockholm, SWE |
|
| 16.30-17.30 | Industry symposium 2, Vifor Pharma Nordiska Ab |
| 18.00- | Jogging by the river Aura with colleagues from Turku Congress dinner |
Sunday, 1 September
| 8.00-9.00 | Industry symposium 3, Baxter Oy |
| 9.00-10.30 | Session 5 – Hypertension (chair: Ilkka Pörsti, Tampere, FIN) |
| Atherosclerotic renovascular disease Niina Koivuviita, Turku, FIN Fibromuscular dysplasia Alexandre Persu, Brussels, BEL |
|
| 10.30-11.00 | Coffee & exhibition |
| 11.00-12.30 | Session 6 – State-of-the-art (chair tba) |
| Treatment of IgA nephropathy Thomas Rauen, Aachen, GER RRT for AKI Claudio Ronco, Vicenza, ITA |
|
| 12.30-13.40 | Lunch and exhibition |
| 13.40-15.00 | Session 7 – eHealth (chair Satu Mäkelä, Tampere, FIN) |
| Digitalization and the change in healthcare Visa Honkanen, Helsinki, FIN Digital innovations in nephrology Virpi Rauta, Helsinki, FIN |
|
| 15.00-15.30 | Coffee and exhibition |
| 15.30-17.00 | Session 8 – Best posters |
| 17.00-18.00 | Industry symposium 4, Sanofi |
| 19.30- | Congress dinner |
Monday, 2 September
| 9.00-10.00 | Industry symposium 4, Medans Oy |
| 10.00-11.30 | Session 9 – Geriatric nephrology (Chair: Heikki Saha, Tampere, FIN) |
| Shared decision making and the option of conservative treatment James Heaf, Copenhagen, DEN Transplantation in the elderly Anna Reisaeter, Oslo, NO Palliative treatment of ESRD patients Emma Murphy, Southampton, UK |
|
| 11.30-12.00 | Coffee and exhibition |
| 12.00-13.30 | Session 10 – State of the Art lectures (chairs: Kaj Metsärinne, Turku, FIN & Helle Thiesson, DEN) |
| Vasculitis 2019 Mårten Segelmark, Lund, SWE The gut-kidney axis Peter Rossing, Copenhagen, DEN Treatment of Membranous glomerulonephritis Eero Honkanen, Helsinki, FIN |
|
| 13.30- | Farewell |
Preliminary Session Topics
- eHealth
- Geriatric nephrology
- Homedialysis
- Transplantation
- Diabetes and kidney disease
- Hypertension
- Coagulation defects in kidney disease
- Pediatric nephrology
- Best posters
- State of the art lectures
- Acute kidney injury